Domestic price and buying guide of olaparib

Olaparib, a targeted therapy drug specially designed for cancer patients carrying BRCA1 or BRCA2 gene mutations, has been successfully launched in China and is widely used in the treatment of ovarian cancer, breast cancer, prostate cancer and pancreatic cancer. BRCAMutations in the gene can lead to impairment of the cell's DNA repair function and increase the risk of cancer. Olaparib effectively blocks cancer cells by precisely inhibiting PARP (polyADP-ribose polymerase), a key protein. The pan>DNA repair pathway causes cancer cells to die due to the accumulation of DNA damage. It has shown remarkable efficacy especially in patients for whom traditional chemotherapy is ineffective.

Since it was first approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of advanced ovarian cancer, olaparib's indications have been continuously expanded to cover multiple cancer types such as triple-negative breast cancer, some pancreatic cancers, and prostate cancers. Compared with traditional chemotherapy drugs, olaparib, as a targeted therapy, has better tolerance and safety. Its common side effects, such as fatigue, nausea, anemia and thrombocytopenia, can usually be alleviated by adjusting the dose or symptomatic treatment.

In the domestic market, olaparib has been included in the medical insurance catalog, reducing financial pressure on patients. Specifically, the price of olaparib in domestic pharmacies is about four to five thousand yuan, which is 150mg*56 tablets. After medical insurance reimbursement, the patient's out-of-pocket ratio will be further reduced. However, specific prices and reimbursement rates may vary by region, and patients are advised to consult their local hospital or pharmacy for accurate information.

In addition, the prices of generic olaparib drugs in some foreign countries, such as Bangladesh and Laos, are relatively affordable. The price of generic drugs of 150mg*120 tablets is about 2,000 yuan. These generic drugs are similar in ingredients and efficacy to the original drugs, providing a more economical choice for patients with limited financial conditions. However, when choosing generic drugs, patients should carefully evaluate the source and quality of the drugs, and use them under the guidance of professional doctors to ensure drug safety.